Cargando…

Novel Oral Anticoagulants in Patients With Atrial Fibrillation and Moderate to Severe Mitral Stenosis: A Systematic Review

The use of novel oral anticoagulants (NOAC) in patients with moderate to severe mitral stenosis (MS) and atrial fibrillation (AF) is not recommended. We aimed to evaluate the efficacy and safety of NOAC usage compared to vitamin K antagonist (VKA) in patients with moderate to severe MS and AF. We co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al Rawahi, Mohamed N, Al-Maqbali, Juhaina S, Al Noumani, Jawahar, Al Alawi, Abdullah M, Essebag, Vidal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2023
Materias:	Cardiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891397/ https://www.ncbi.nlm.nih.gov/pubmed/36741597 http://dx.doi.org/10.7759/cureus.33222

Ejemplares similares

Pericardial Effusion in Erdheim-Chester Disease: A Case Report and a Mini Literature Review
por: Al Hinai, Juhaina, et al.
Publicado: (2022)

Extensive Arterial and Venous Thrombosis in a Female With a Known Untreated Polycystic Ovarian Syndrome: A Case Report
por: Al Busaidi, Salim A, et al.
Publicado: (2023)

Prevalence, Recognition, and Risk Factors of Constipation among Medically Hospitalized Patients: A Cohort Prospective Study
por: Al Nou’mani, Jawahar, et al.
Publicado: (2023)

Clinical Associations with the differences in rivaroxaban dosing in patients with atrial fibrillation stratified by three renal function formulae
por: Al-Maqbali, Juhaina Salim, et al.
Publicado: (2023)

Obesity Paradox in Atrial Fibrillation and its Relation with the New Oral Anticoagulants
por: Filho, André Inocêncio Novaes Lima, et al.
Publicado: (2022)

Efficacy and Safety of Direct Oral Anticoagulant for Treatment of Atrial Fibrillation in Cerebral Amyloid Angiopathy
por: Narita, Koichi, et al.
Publicado: (2020)

The Frequency of Left Atrial Thrombus on Transthoracic Echocardiogram in Patients with Mitral Stenosis
por: Ahmed, Khalil, et al.
Publicado: (2020)

Comparison Between Oral Anticoagulation and Left Atrial Appendage Occlusion in the Prevention of Stroke With Regard to Non-Valvular Atrial Fibrillation
por: Sandhu, Osama, et al.
Publicado: (2020)

A 59-Year-Old Woman with Extensive Deep Vein Thrombosis and Pulmonary Thromboembolism 7 Days Following a First Dose of the Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine
por: Al-Maqbali, Juhaina Salim, et al.
Publicado: (2021)

The Effectiveness and Safety of Direct Oral Anticoagulants in Obese Patients With Atrial Fibrillation: A Network Meta-Analysis
por: Salah, Qais M, et al.
Publicado: (2023)

Thyrotoxicosis Periodic Paralysis: A Rare Presentation of a Common Disease
por: Al Noumani, Jawahar, et al.
Publicado: (2022)

Incidence and Risk Factors for 28 Days Hospital Readmission: A Retrospective Study from Oman
por: Al Sibani, Maitha, et al.
Publicado: (2022)

Rare Coronary Embolism Secondary to Cardioversion of Atrial Fibrillation
por: Alkhatib, Deya, et al.
Publicado: (2022)

Obesity and Atrial Fibrillation: Should We Screen for Atrial Fibrillation in Obese Individuals? A Comprehensive Review
por: Ghattas, Kyrillos N, et al.
Publicado: (2020)

Effect of direct oral anticoagulants in patients with atrial fibrillation with mitral or aortic stenosis: A review
por: Guo, Guigao, et al.
Publicado: (2022)

Early Versus Delayed Oral Anticoagulation in Patients With Acute Ischemic Stroke Due to Atrial Fibrillation: A Meta-Analysis
por: Tirumandyam, Gayathri, et al.
Publicado: (2023)

Association between Non-Steroidal Anti-Inflammatory Drug Use and Major Cardiovascular Outcomes in Patients with Acute Coronary Syndrome in the Arabian Gulf
por: Al-Zakwani, Ibrahim, et al.
Publicado: (2023)

Acute Mesenteric Ischemia in a Chronically Anticoagulated Patient With Atrial Fibrillation: Anticoagulation Reversal, Management and Preventing Recurrence
por: Aziz, Ahmed Ali, et al.
Publicado: (2022)

Use of Anticoagulants in Patients With Non-Valvular Atrial Fibrillation Who Are at Risk of Falls
por: Shanah, Layla, et al.
Publicado: (2020)

Mitral stenosis and atrial fibrillation
por: Westermann, Dirk, et al.
Publicado: (2020)

Incidence, patterns, risk factors and clinical outcomes of intravenous acyclovir induced nephrotoxicity
por: Al-Alawi, Abdullah M., et al.
Publicado: (2022)

The Integration of Artificial Intelligence Into Patient Care: A Case of Atrial Fibrillation Caught by a Smartwatch
por: Bedi, Angad, et al.
Publicado: (2023)

Rivaroxaban for Treatment of Left Ventricular Thrombus: A Case Report
por: Al-Maqbali, Juhaina Salim, et al.
Publicado: (2021)

Assessment of Awareness Levels About Anticoagulants in Patients With Atrial Fibrillation Presenting to Emergency Department
por: Akman, Canan, et al.
Publicado: (2021)

Systematic Review and Meta-Analysis: Can We Compare Direct Oral Anticoagulants to Warfarin in Patients With Atrial Fibrillation and Bio-Prosthetic Valves?
por: Adhikari, Govinda, et al.
Publicado: (2021)

Guideline-directed medical therapy in heart failure patients with reduced ejection fraction in Oman: utilization, reasons behind non-prescribing, and dose optimization
por: Al-Aghbari, Safiya, et al.
Publicado: (2022)

Late-Onset COVID-19-Related Multi-System Inflammatory Syndrome in a Middle-Aged Man
por: Al-Falahi, Zubaida, et al.
Publicado: (2021)

Left atrial appendage isolation in atrial fibrillation catheter ablation: A meta‐analysis
por: AlTurki, Ahmed, et al.
Publicado: (2018)

Subclinical Atrial Fibrillation and Risk of Stroke: Past, Present and Future
por: AlTurki, Ahmed, et al.
Publicado: (2019)

Expert Opinion on the Use of Novel Oral Anticoagulants for Stroke Prevention in Non-valvular Atrial Fibrillation for the Primary Care Setting in India: A Literature Review
por: Dalal, Jamshed, et al.
Publicado: (2022)

Oral Anticoagulation in Patients With Atrial High-Rate Episodes: Focus on Clinical Implications
por: Dimou, Smaro, et al.
Publicado: (2023)

Giant Left Atrial Thrombus Despite Anticoagulation with Apixaban in a Patient with Mitral Stenosis and Atrial Fibrillation
por: Turek, Łukasz, et al.
Publicado: (2021)

Cardiac Tamponade Risk Associated With Anticoagulation for Atrial Fibrillation in Dialysis-Associated Pericarditis: A Case Report
por: Abu-Abaa, Mohammad, et al.
Publicado: (2023)

Incidence of Dysmagnesemia among Medically Hospitalized Patients and Associated Clinical Characteristics: A Prospective Cohort Study
por: Al Shukri, Zahra, et al.
Publicado: (2023)

Non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation in secondary stroke and systemic embolism prevention
por: Gorczyca, Iwona, et al.
Publicado: (2019)

The Stability of Analytes of Ionized Magnesium Concentration and Its Reference Range in Healthy Volunteers
por: Al-Maqbali, Juhaina Salim, et al.
Publicado: (2023)

Clinical characteristics and health outcomes in patients with alcohol withdrawal syndrome: an observational study from Oman
por: Al-Maqbali, Juhaina Salim, et al.
Publicado: (2022)

Ischemic Stroke in a Patient With Atrial Tachycardia, Methylenetetrahydrofolate Reductase Mutation and New-Onset Atrial Fibrillation: Is Early Initiation of Anticoagulation Therapy Indicated?
por: Eyituoyo, Harry O, et al.
Publicado: (2020)

Risk of Stroke With Mitral Stenosis: The Underlying Mechanism, Treatment, and Prevention
por: Islam, Hamza, et al.
Publicado: (2022)

Use of New Oral Anticoagulants / Direct Oral Anticoagulants in Malignant Patients
por: Khan, Yusra, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t7g05eul34nq41nbufenr2rti8